Roivant Sciences (ROIV) Non-Current Debt (2021 - 2024)
Roivant Sciences (ROIV) posted Non-Current Debt of $311.7 million for Q2 2024, down 27.61% on a QoQ basis from $430.6 million in Q1 2024, and down 19.05% year-over-year from $385.1 million in Q3 2023.
Roivant Sciences (ROIV) Non-Current Debt (2021 - 2024) Analysis & Trends
Roivant Sciences' Non-Current Debt history runs 4 years deep, the most recent figure standing at $311.7 million for Q2 2024.
- Quarterly Non-Current Debt fell 19.05% year-over-year to $311.7 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $311.7 million (down 19.05% YoY) and the FY2024 annual result came in at $430.6 million, up 14.67% from the prior year.
- Non-Current Debt was $311.7 million for Q2 2024 at Roivant Sciences, down from $430.6 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $430.6 million in Q1 2024 and bottomed at $170.3 million in Q1 2021.
- A 4-year average of $314.4 million and a median of $375.3 million in 2022 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt surged 105.91% — and 2024, when it fell 19.05%.
- Roivant Sciences' Non-Current Debt stood at $204.0 million in 2021, then soared by 83.85% to $375.1 million in 2022, then increased by 7.52% to $403.3 million in 2023, then slipped by 22.72% to $311.7 million in 2024.
- Business Quant data shows ROIV's Non-Current Debt at $311.7 million in Q2 2024, $430.6 million in Q1 2024, and $403.3 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 311.72 Mn |
| Mar 31, 2024 | 430.59 Mn |
| Dec 31, 2023 | 403.34 Mn |
| Sep 30, 2023 | 389.45 Mn |
| Jun 30, 2023 | 385.07 Mn |
| Mar 31, 2023 | 375.52 Mn |
| Dec 31, 2022 | 375.12 Mn |
| Sep 30, 2022 | 376.06 Mn |
| Jun 30, 2022 | 383.72 Mn |
| Mar 31, 2022 | 210.03 Mn |
| Dec 31, 2021 | 204.04 Mn |
| Sep 30, 2021 | 199.87 Mn |
| Jun 30, 2021 | 186.35 Mn |
| Mar 31, 2021 | 170.28 Mn |